2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment

News provided by

Jul 11, 2012, 07:18 ET

NEW YORK, July 11, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: 2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment

http://www.reportlinker.com/p0845325/2012-Global-APTT-Market-Outlook-Test-Volume-Forecasts-by-Country-and-Market-Segment.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and APTT testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the APTT testing closer to the patient, creating additional opportunities and challenges for suppliers.

This report presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 198 pages and 8 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. Introduction

B. Activated Partial Thromboplastin Time (APTT): Clinical Significance

and Current Laboratory Procedures

C. Instrumentation Review

- Introduction

- Benk Hemolab

- Benk TRT Thrombotimer

- Bio/Data MCA 310

- Bio/Data MCA 210

- Bio/Data PAP-4C D/4D/4C

- Cardiovascular Diagnostics COAG

- Diagnostica Stago STA Compact

- Diagnostica Stago STA-R

- Diagnostica Stago Star 4/8

- Helena Laboratories Cascade 480

- Helena Laboratories Cascade M

- Helena Laboratories PACKS-4

- Helena THOR

- Instrumentation Laboratory ACL 100 and 1000 series

- Instrumentation Laboratory ACL6000

- Instrumentation Laboratory ACL7000

- Instrumentation Laboratory ACL9000

- Instrumentation Laboratory Electra 1000C

- Instrumentation Laboratory Electra 1400C

- Instrumentation Laboratory Electra 1600/C

- Instrumentation Laboratory Electra 1800C

- Instrumentation Laboratory Futura

- ITC Hemochron 8000

- Roche Diagnostics CoaguChek

- Siemens BCS

- Siemens BCT

- Siemens BF II/Fibrintimer Series

- Sysmex CA-50

- Sysmex CA-500

- Sysmex CA-1500

- Sysmex CA-5000/CA-1000

- Sysmex CA-6000

- Sysmex CA-7000

- Teco Coatron II/Jr./AccuStasis 5000

- Trinity Biotech Amax CS190

- Trinity Biotech Amax CS400

- Trinity Biotech Coag-A-Mate Max

- Trinity Biotech KC 40, 4A, 1A Series

- Trinity Biotech MDA 180

- Trinity Biotech Coag-A-Mate MTX

- Trinity Biotech Coag-A-Mate RA4

- Trinity Biotech Coag-A-Mate XC/Plus

- Trinity Biotech Coag-A-Mate XM

D. Major in Vitro Diagnostic Technologies and Their

Potential Applications

1. Chromogenic Substrates

2. Monoclonal and Polyclonal Antibodies

3. Immunoassays

a. Applications

b. Technological Principle

c. Enzyme Immunoassays (EIA)

- Overview

- ELISA

- EMIT

- Dot Immunobinding Assays

- Capillary Immunoassays

- Enzyme Amplification

- Electrochemical Immunoassay

d. Fluorescent Immunoassays

- Fluorescence Polarization

- Time-Resolved Pulse Fluorescence

- Fluorescence Lifetime

e. Latex Agglutination

f. Immunoprecipitation

4. Microcomputers

5. Automation

6. Robotics

7. DNA Probes

a. Overview

b. Amplification Methods

- PCR

- Ligase Chain Reaction

- Branched DNA

- Q-Beta Replicase

- NASBA

- SDA

- 3 SR

- HPA

- Two-Tiered System

- LAT

8. Artificial Intelligence

9. Dry Chemistry

10. Biosensors

III. France: Test Volume Forecasts by Market Segment

IV. Germany: Test Volume Forecasts by Market Segment

V. Italy: Test Volume Forecasts by Market Segment

VI. Japan: Test Volume Forecasts by Market Segment

VII. Spain: Test Volume Forecasts by Market Segment

VIII. UK: Test Volume Forecasts by Market Segment

IX. USA: Test Volume Forecasts by Market Segment

X. Design Criteria For Decentralized Testing Products

XI. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types Of Distributors

7. Market Segmentation

XII. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

XIII. Competitive Assessments

- Abbott

- American Diagnostica

- Avocet Medical

- Axis-Shield

- Beckman Coulter

- Becton Dickinson

- Bio/Data Corporation

- Biosite

- Chrono-Log

- Corgenix Medical

- Diagnostica Stago

- Helena Laboratories

- HYPEN BioMed

- Instrumentation Laboratory

- ITC

- Nanogen

- Roche

- Siemens

- Sienco

- Sysmex

- Thermo Fischer

- Trinity Biotech

- ZyCare

APTT: US, EUROPE, JAPAN

Test Volume Forecasts by Country and Market Segment

List of Tables

Major Companies Developing or Marketing APTT Tests

France